Propafenone News and Research

RSS
Anti-arrhythmic agents linked to increased risk of falls

Anti-arrhythmic agents linked to increased risk of falls

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Study supports catheter ablation as first-line treatment for paroxysmal atrial fibrillation

Study supports catheter ablation as first-line treatment for paroxysmal atrial fibrillation

Par Pharmaceutical reports second quarter total revenues of $224.2 million

Par Pharmaceutical reports second quarter total revenues of $224.2 million

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

KV Pharmaceutical makes agreement with U.S. Department of Justice to resolve investigation on ETHEX

KV Pharmaceutical makes agreement with U.S. Department of Justice to resolve investigation on ETHEX

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

FDA grants approval for Abbott's antiretroviral medication Norvir

FDA grants approval for Abbott's antiretroviral medication Norvir

Ablation therapy better than drug therapy for heart rhythm disorder

Ablation therapy better than drug therapy for heart rhythm disorder

Catheter ablation effective for atrial fibrillation

Catheter ablation effective for atrial fibrillation

Catheter ablation works better than drugs for heart rhythm disorder

Catheter ablation works better than drugs for heart rhythm disorder

GlaxoSmithKline to acquire Reliant Pharmaceuticals

GlaxoSmithKline to acquire Reliant Pharmaceuticals